[Summary of the clinical studies reported in the scientific session of the American Heart Association 2005 (Dallas, Texas, USA, 13-16 November 2005)].
Bermejo
Javier
J
Sociedad Española de Cardiología, Nuestra Señora de Guadalupe, Madrid, España.
Segovia
Javier
J
Alfonso
Fernando
F
D015906:Angioplasty, Balloon, Coronary; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D002309:Cardiology / Q000639:trends*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003226:Congresses as Topic; D003324:Coronary Artery Disease / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D006331:Heart Diseases / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D006333:Heart Failure / Q000188:drug therapy / Q000401:mortality; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006973:Hypertension / Q000188:drug therapy; D009203:Myocardial Infarction / Q000517:prevention & control / Q000628:therapy; D009204:Myocardial Revascularization; D016540:Smoking Cessation; D012955:Societies, Medical; D033581:Stem Cell Transplantation; D013234:Stem Cells; D015607:Stents
D000924:Anticholesteremic Agents